Comparison of standardized uptake value ratio calculations in amyloid positron emission tomography brain imaging

Comparison of standardized uptake value ratio calculations in amyloid positron emission tomography brain imaging

Amyloid positron emission tomography (PET) imaging with florbetapir 18F (18F-AV-45) allows in vivo assessment of cerebral amyloid load and can be used in the evaluation of progression of Alzheimer's disease (AD) and other dementias associated with b-amyloid. However, cortical amyloid deposition...

Full description

Saved in:

Bibliographic Details
Main Authors:	Karin Knesaurek, Geoffrey Warnock, Lale Kostakoglu, Cyrill Burger
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2018-01-01
Series:	World Journal of Nuclear Medicine
Subjects:	alzheimer's disease florbetapir positron emission tomography amyloid imaging
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.4103/wjnm.WJNM_5_17
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Association Between Constipation and Positron Emission Tomography and Blood-Based Biomarkers in Older Cognitively Unimpaired Adults with Higher Amyloid-β Burden
by: Heling Chu, et al.
Published: (2024-10-01)

Improving 18F-Fluoro-D-Glucose-Positron Emission Tomography/Computed Tomography Imaging in Alzheimer′s Disease Studies
by: Karin Knešaurek
Published: (2015-07-01)

Accuracy of quantitative positron emission tomography assessment for differentiating cerebral age-related from pathological amyloid deposition: A preliminary report from a case-series study
by: Fulvio Lauretani, et al.
Published: (2018-04-01)

Comparative Diagnostic Performance of Amyloid‐β Positron Emission Tomography and Magnetic Resonance Imaging in Alzheimer's Disease: A Head‐to‐Head Meta‐Analysis
by: Fang Li, et al.
Published: (2024-10-01)

Non-standard pipeline without MRI has replicability in computation of Centiloid scale values for PiB and 18F-labeled amyloid PET tracers
by: Motonobu Fujishima, et al.
Published: (2022-09-01)

Positron Emission Tomography in Cerebral Amyloid Angiopathy: A Scoping Review
by: Marialuisa Zedde, et al.
Published: (2025-04-01)

Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
by: Sebastian Palmqvist, et al.
Published: (2019-11-01)

Estimating the optimal cutoff for the IGT‐AD Distress subscale adapted for amyloid PET results disclosure
by: Dianxu Ren, et al.
Published: (2025-04-01)

Comparison of plasma p-tau217 and p-tau181 in predicting amyloid positivity and prognosis among Korean memory clinic patients
by: Hyuk Sung Kwon, et al.
Published: (2025-03-01)

Ultra-fast [18F]florbetapir PET imaging using the uMI Panorama PET/CT system
by: Xueqian Yang, et al.
Published: (2024-12-01)

Phototherapy via Modulation of β‐Amyloid in Combating Alzheimer's Disease
by: Yunhua Zhang, et al.
Published: (2025-05-01)

Amyloid-Related Imaging Abnormalities in Anti-Amyloid Monoclonal Antibody Therapy for Alzheimer’s Disease: Expert Recommendation for Standard MRI Protocol
by: Jimin Kim, et al.
Published: (2025-01-01)

From clinical phenotype to proteinopathy: molecular neuroimaging in neurodegenerative dementias
by: Adalberto Studart-Neto, et al.
Published: (2022-08-01)

Calculations of Cross-Sections for Positron Scattering on Benzene
by: Małgorzata Franz, et al.
Published: (2024-12-01)

Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
by: Niklas Mattsson‐Carlgren, et al.
Published: (2021-05-01)

Immune cell responses to amyloid-beta proteins: What is the extent and implications of amyloid-beta induced cytotoxicity in microglial cells and peripheral blood mononuclear cells?
by: Cao, A.
Published: (2017-07-01)

POSITRON EMISSION TOMOGRAPHY IN GYNECOLOGIC ONCOLOGY
by: D. V. Ryzhkova, et al.
Published: (2016-02-01)

Poor uptake of fluorodeoxyglucose in positron emission tomography-computed tomography scan for intraocular choroidal melanoma in Asian Indian Eyes
by: Rahul Sharma, et al.
Published: (2016-01-01)

Nanomaterials in targeting amyloid-β oligomers: current advances and future directions for Alzheimer's disease diagnosis and therapy
by: Shiwani Randhawa, et al.
Published: (2025-04-01)

Development of a Japanese polygenic risk score model for amyloid-β PET imaging in Alzheimer’s disease
by: Misato Kaishima, et al.
Published: (2025-05-01)

Targeted Magnetic Nanoparticles for Beta-Amyloid Detection
by: Nelly S. Chmelyuk, et al.
Published: (2024-10-01)

Bilateral Diffuse Fluorodeoxyglucose Uptake in Thyroid Gland Diagnosed by Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography
by: Aung Win, et al.
Published: (2014-04-01)

Reduced protein solubility – cause or consequence in amyloid disease?
by: Max Lindberg, et al.
Published: (2025-01-01)

Amyloid immunotherapy for Alzheimer's disease: the case for cautious adoption
by: Jonathan M. Schott, et al.
Published: (2025-05-01)

Positron emission tomography–computed tomography-associated incidental neoplasms of the thyroid gland
by: K Kamakshi, et al.
Published: (2020-01-01)

NGP 555, a γ‐secretase modulator, shows a beneficial shift in the ratio of amyloid biomarkers in human cerebrospinal fluid at safe doses
by: Maria Z. Kounnas, et al.
Published: (2019-01-01)

CD22 modulation alleviates amyloid β-induced neuroinflammation
by: Yu Dong Mai, et al.
Published: (2025-02-01)

Unraveling the complex role of microglia in Alzheimer’s disease: amyloid β metabolism and plaque formation
by: Sho Takatori, et al.
Published: (2025-05-01)

Deletion of Murine APP Aggravates Tau and Amyloid Pathologies in the 5xFADXTg30 Alzheimer’s Disease Model
by: Kunie Ando, et al.
Published: (2025-01-01)

Amyloid-β Inhibiting Peptides: An Innovative Strategy for Alzheimer’s Disease Treatment
by: Sajjad Molavipordanjani, et al.
Published: (2023-11-01)

Chimeric antigen receptors discriminate between tau and distinct amyloid-beta species
by: Cynthia J. Siebrand, et al.
Published: (2025-05-01)

Potential utility of salivary gland amyloid uptake as a surrogate marker for adipose tissue and amyloid-beta dynamics based on its association with BMI and cerebral amyloid burden
by: Kyu Ri Kim, et al.
Published: (2025-07-01)

Tumor volume delineation: A pilot study comparing a digital positron-emission tomography prototype with an analog positron-emission tomography system
by: Nghi C. Nguyen, et al.
Published: (2019-01-01)

Role of Graphene Oxide in Disentangling Amyloid Beta Fibrils
by: Brianna Duswalt, et al.
Published: (2024-10-01)

S100A8 Interaction with Amyloid-β Peptide Suppresses Its Fibrillation
by: Ekaterina Litus, et al.
Published: (2024-04-01)

Predicting amyloid proteins using attention-based long short-term memory
by: Zhuowen Li
Published: (2025-02-01)

Application of the revised criteria for diagnosis and staging of Alzheimer's disease: Drug development and clinical practice
by: Clifford R. Jack, et al.
Published: (2024-10-01)

β-Amyloids and Immune Responses Associated with Alzheimer’s Disease
by: Elizaveta Kolobova, et al.
Published: (2024-09-01)

Positron Emission Tomography Imaging in Sarcoidosis
by: Beth Vettiyil, et al.
Published: (2013-07-01)

Positron emission tomography tracers for synucleinopathies
by: Jie Xiang, et al.
Published: (2025-01-01)